{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:59:52Z","timestamp":1792450792219,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Plan on enhancing scientific research in GMU","award":["GMUCR2025-02016"],"award-info":[{"award-number":["GMUCR2025-02016"]}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024A03J1228&2024A03J1157"],"award-info":[{"award-number":["2024A03J1228&2024A03J1157"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82001879 &82402418"],"award-info":[{"award-number":["No. 82001879 &82402418"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["No. 2024A03J1080"],"award-info":[{"award-number":["No. 2024A03J1080"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["No. 2024A03J1080"],"award-info":[{"award-number":["No. 2024A03J1080"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project of Guangzhou National Laboratory","award":["GZNL2025A02002"],"award-info":[{"award-number":["GZNL2025A02002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"DOI":"10.1007\/s00259-026-08094-9","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:49:32Z","timestamp":1785401372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["[18F]FAPI-42 PET\/CT for prognostic assessment in idiopathic pulmonary fibrosis: a prospective head-to-head comparison with [18F]FDG PET\/CT"],"prefix":"10.1007","author":[{"given":"Qi","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvlu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingpeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-5687","authenticated-orcid":false,"given":"XinLu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"8094_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S2213-2600(25)00045-1","volume":"13","author":"A Alonso-Gonz\u00e1lez","year":"2025","unstructured":"Alonso-Gonz\u00e1lez A, J\u00e1spez D, Lorenzo-Salazar JM, Ma S-F, Strickland E, Mychaleckyj J, et al. Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation. Lancet Respiratory Med. 2025;13:495\u2013504. https:\/\/doi.org\/10.1016\/S2213-2600(25)00045-1.","journal-title":"Lancet Respiratory Med"},{"key":"8094_CR2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.rcl.2016.05.004","volume":"54","author":"JE Kusmirek","year":"2016","unstructured":"Kusmirek JE, Martin MD, Kanne JP. Imaging of Idiopathic Pulmonary Fibrosis. Radiologic Clin. 2016;54:997\u20131014. https:\/\/doi.org\/10.1016\/j.rcl.2016.05.004.","journal-title":"Radiologic Clin"},{"key":"8094_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1164\/rccm.202403-0659ED","volume":"210","author":"L Calandriello","year":"2024","unstructured":"Calandriello L. Quantitative Computed Tomography in Idiopathic Pulmonary Fibrosis: Is It Time to Act? Am J Respir Crit Care Med. 2024;210:382\u20133. https:\/\/doi.org\/10.1164\/rccm.202403-0659ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2967\/jnumed.116.174946","volume":"57","author":"T Nobashi","year":"2016","unstructured":"Nobashi T, Kubo T, Nakamoto Y, Handa T, Koyasu S, Ishimori T, et al. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease. J Nucl Med. 2016;57:1899\u2013904. https:\/\/doi.org\/10.2967\/jnumed.116.174946.","journal-title":"J Nucl Med"},{"key":"8094_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00259-017-3917-8","volume":"45","author":"T Win","year":"2018","unstructured":"Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, et al. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2018;45:806\u201315. https:\/\/doi.org\/10.1007\/s00259-017-3917-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8094_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0556-3","volume":"18","author":"A Justet","year":"2017","unstructured":"Justet A, Laurent-Bellue A, Thabut G, Dieudonn\u00e9 A, Debray MP, Borie R, et al. [(18)F]FDG PET\/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res. 2017;18:74. https:\/\/doi.org\/10.1186\/s12931-017-0556-3.","journal-title":"Respir Res"},{"key":"8094_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0974-5","volume":"20","author":"B Bondue","year":"2019","unstructured":"Bondue B, Castiaux A, Van Simaeys G, Mathey C, Sherer F, Egrise D, et al. Absence of early metabolic response assessed by 18F-FDG PET\/CT after initiation of antifibrotic drugs in IPF patients. Respir Res. 2019;20:10. https:\/\/doi.org\/10.1186\/s12931-019-0974-5.","journal-title":"Respir Res"},{"key":"8094_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081103","volume":"14","author":"LH Jordon","year":"2024","unstructured":"Jordon LH, Ganeshan B, Nadeem I, Hoy L, Mahdi N, Porter JC, et al. Can FDG-PET\/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting. BMJ Open. 2024;14:e081103. https:\/\/doi.org\/10.1136\/bmjopen-2023-081103.","journal-title":"BMJ Open"},{"key":"8094_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00259-013-2579-4","volume":"41","author":"S Abdulla","year":"2014","unstructured":"Abdulla S, Salavati A, Saboury B, Basu S, Torigian DA, Alavi A. Quantitative assessment of global lung inflammation following radiation therapy using FDG PET\/CT: a pilot study. Eur J Nucl Med Mol Imaging. 2014;41:350\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8094_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.114.147421","volume":"56","author":"B Bondue","year":"2015","unstructured":"Bondue B, Sherer F, Van Simaeys G, Doumont G, Egrise D, Yakoub Y, et al. PET\/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. J Nucl Med. 2015;56:127\u201332.","journal-title":"J Nucl Med"},{"key":"8094_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2967\/jnumed.108.057901","volume":"50","author":"AM Groves","year":"2009","unstructured":"Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, et al. Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease: Implications from Initial Experience with 18F-FDG PET\/CT. J Nucl Med. 2009;50:538\u201345.","journal-title":"J Nucl Med"},{"key":"8094_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000514","volume":"8","author":"JM Lemons","year":"2010","unstructured":"Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 2010;8:e1000514.","journal-title":"PLoS Biol"},{"key":"8094_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13122018","author":"KR Chandekar","year":"2023","unstructured":"Chandekar KR, Prashanth A, Vinjamuri S, Kumar R. FAPI PET\/CT imaging-an updated review. Diagnostics (Basel). 2023. https:\/\/doi.org\/10.3390\/diagnostics13122018.","journal-title":"Diagnostics (Basel)"},{"key":"8094_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","volume":"207","author":"P Yang","year":"2023","unstructured":"Yang P, Luo Q, Wang X, Fang Q, Fu Z, Li J, et al. Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases. Am J Respir Crit Care Med. 2023;207:160\u201372. https:\/\/doi.org\/10.1164\/rccm.202110-2414OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR15","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/s2665-9913(20)30421-5","volume":"3","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, Distler JHW, Treutlein C, Tascilar K, M\u00fcller A-T, Atzinger A, et al. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. Lancet Rheumatol. 2021;3:e185\u201394. https:\/\/doi.org\/10.1016\/s2665-9913(20)30421-5.","journal-title":"Lancet Rheumatol"},{"key":"8094_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102598","volume":"72","author":"K Kastrati","year":"2024","unstructured":"Kastrati K, Nakuz TS, Kulterer OC, Ge\u00dfl I, Simader E, Mrak D, et al. FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study. eClinicalMedicine. 2024;72:102598. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102598.","journal-title":"eClinicalMedicine"},{"key":"8094_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.121.261925","volume":"63","author":"M Rohrich","year":"2022","unstructured":"Rohrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, et al. Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med. 2022;63:127\u201333. https:\/\/doi.org\/10.2967\/jnumed.121.261925.","journal-title":"J Nucl Med"},{"key":"8094_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103856","volume":"24","author":"M Bundgaard-Nielsen","year":"2025","unstructured":"Bundgaard-Nielsen M, Johnsen RH, Mortensen J, Shaker SB, Nielsen CTH. Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases - a systematic review. Autoimmun Rev. 2025;24:103856. https:\/\/doi.org\/10.1016\/j.autrev.2025.103856.","journal-title":"Autoimmun Rev"},{"key":"8094_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-025-01340-5","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang X, Liu Y, Zhou Y, Yang G, Fu C, et al. (99m)Tc-labeled FAPI SPECT and (18)F-FDG PET imaging for visualization and evaluation of connective tissue disease-associated interstitial lung disease. EJNMMI Res. 2025. https:\/\/doi.org\/10.1186\/s13550-025-01340-5.","journal-title":"EJNMMI Res"},{"key":"8094_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277\u2013304. https:\/\/doi.org\/10.1164\/ajrccm.165.2.ats01.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR22","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636\u201343. https:\/\/doi.org\/10.1164\/rccm.200703-463PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"8094_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684\u201391. https:\/\/doi.org\/10.7326\/0003-4819-156-10-201205150-00004.","journal-title":"Ann Intern Med"},{"key":"8094_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11307-021-01679-w","volume":"24","author":"Y Li","year":"2022","unstructured":"Li Y, Lin X, Li Y, Lv J, Hou P, Liu S, et al. Clinical utility of F-18 labeled fibroblast activation protein inhibitor (FAPI) for primary staging in lung adenocarcinoma: a prospective study. Mol Imaging Biol. 2022;24:309\u201320. https:\/\/doi.org\/10.1007\/s11307-021-01679-w.","journal-title":"Mol Imaging Biol"},{"key":"8094_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7:206. https:\/\/doi.org\/10.1038\/s41392-022-01070-3.","journal-title":"Signal Transduct Target Ther"},{"key":"8094_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39:783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"key":"8094_CR28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00022-2025","author":"N Watanabe","year":"2025","unstructured":"Watanabe N, Yoshida M, Hirano Y, Fujimoto S, Matsubayashi S, Ishiguro T, et al. Integrated spatial and single-cell transcriptomics reveal PAK kinase as a therapeutic target in fibroblastic foci and dense fibrosis of idiopathic pulmonary fibrosis. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.00022-2025.","journal-title":"Eur Respir J"},{"key":"8094_CR29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1378\/chest.12-1359","volume":"143","author":"S El-Chemaly","year":"2013","unstructured":"El-Chemaly S, Malide D, Yao J, Nathan SD, Rosas IO, Gahl WA, et al. Glucose transporter-1 distribution in fibrotic lung disease. Chest. 2013;143:1685\u201391. https:\/\/doi.org\/10.1378\/chest.12-1359.","journal-title":"Chest"},{"key":"8094_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2967\/jnumed.123.266445","volume":"65","author":"JC Porter","year":"2024","unstructured":"Porter JC, Ganeshan B, Win T, Fraioli F, Khan S, Rodriguez-Justo M, et al. [18F]FDG PET\/CT signal correlates with neoangiogenesis markers in patients with fibrotic interstitial lung disease who underwent lung biopsy: implication for the use of PET\/CT in diffuse lung diseases. J Nucl Med. 2024;65:617\u201322. https:\/\/doi.org\/10.2967\/jnumed.123.266445.","journal-title":"J Nucl Med"},{"key":"8094_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00259-013-2514-8","volume":"41","author":"T Win","year":"2013","unstructured":"Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2013;41:337\u201342. https:\/\/doi.org\/10.1007\/s00259-013-2514-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8094_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07710-4","author":"SB Tai","year":"2026","unstructured":"Tai SB, Chua WM, Ng CWQ, Noviani M, Tham WP, Saffari SE, et al. Exploratory evaluation of early (68)Ga-FAPI-46 PET\/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease. Eur J Nucl Med Mol Imaging. 2026. https:\/\/doi.org\/10.1007\/s00259-025-07710-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8094_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/thoraxjnl-2011-201184","volume":"67","author":"L Richeldi","year":"2012","unstructured":"Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, et al. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax. 2012;67:407\u201311. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-201184.","journal-title":"Thorax"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08094-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:03:16Z","timestamp":1785445396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08094-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":33,"alternative-id":["8094"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08094-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki, registered in the Chinese Clinical Trial Registry (ChiCTR2100045352) and approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (ES-2020-10).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}